These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24664850)

  • 1. Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases.
    Chen XJ; Xu H; Cooper HM; Liu Y
    Sci China Life Sci; 2014 Apr; 57(4):372-7. PubMed ID: 24664850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic dynein in neurodegeneration.
    Eschbach J; Dupuis L
    Pharmacol Ther; 2011 Jun; 130(3):348-63. PubMed ID: 21420428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of axonal transport in neurodegenerative diseases.
    De Vos KJ; Grierson AJ; Ackerley S; Miller CC
    Annu Rev Neurosci; 2008; 31():151-73. PubMed ID: 18558852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of axonal transport in neurodegeneration.
    Berth SH; Lloyd TE
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in cytoplasmic dynein and its regulators cause malformations of cortical development and neurodegenerative diseases.
    Lipka J; Kuijpers M; Jaworski J; Hoogenraad CC
    Biochem Soc Trans; 2013 Dec; 41(6):1605-12. PubMed ID: 24256262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neurons rely on motor proteins.
    Holzbaur EL
    Trends Cell Biol; 2004 May; 14(5):233-40. PubMed ID: 15130579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynein: An ancient motor protein involved in multiple modes of transport.
    Vallee RB; Williams JC; Varma D; Barnhart LE
    J Neurobiol; 2004 Feb; 58(2):189-200. PubMed ID: 14704951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic dynein is associated with slow axonal transport.
    Dillman JF; Dabney LP; Pfister KK
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):141-4. PubMed ID: 8552592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Axonal Transport by Protein Kinases.
    Gibbs KL; Greensmith L; Schiavo G
    Trends Biochem Sci; 2015 Oct; 40(10):597-610. PubMed ID: 26410600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small heat shock proteins in neurodegenerative diseases.
    Vendredy L; Adriaenssens E; Timmerman V
    Cell Stress Chaperones; 2020 Jul; 25(4):679-699. PubMed ID: 32323160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in dynein link motor neuron degeneration to defects in retrograde transport.
    Hafezparast M; Klocke R; Ruhrberg C; Marquardt A; Ahmad-Annuar A; Bowen S; Lalli G; Witherden AS; Hummerich H; Nicholson S; Morgan PJ; Oozageer R; Priestley JV; Averill S; King VR; Ball S; Peters J; Toda T; Yamamoto A; Hiraoka Y; Augustin M; Korthaus D; Wattler S; Wabnitz P; Dickneite C; Lampel S; Boehme F; Peraus G; Popp A; Rudelius M; Schlegel J; Fuchs H; Hrabe de Angelis M; Schiavo G; Shima DT; Russ AP; Stumm G; Martin JE; Fisher EM
    Science; 2003 May; 300(5620):808-12. PubMed ID: 12730604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitophagy in neurodegenerative diseases.
    Rodolfo C; Campello S; Cecconi F
    Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Releasing the brake: restoring fast axonal transport in neurodegenerative disorders.
    Hinckelmann MV; Zala D; Saudou F
    Trends Cell Biol; 2013 Dec; 23(12):634-43. PubMed ID: 24091156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.